Zhiqian Zhang

机构：The University of Texas MD Anderson Cancer Center, China University of Mining and Technology, Southern University of Science and Technology · ORCID：0000-0003-1226-4807

发表论文 125 篇 · 总被引 2211 次 · h-index 29

代表论文

• Hederagenin suppresses ovarian cancer via targeting mitochondrial fission through dynamin-related protein 1 (2023 · European Journal of Pharmacology · 被引 12)
• Editorial: Epigenetic drugs and therapeutic resistance for epithelial malignancies (2023 · Frontiers in Pharmacology · 被引 8)
• Regulation of hPCL3 isoforms’ ubiquitination by TRIM21 in non-small cell lung cancer progression (2023 · Life Science Alliance · 被引 5)
• An 18-gene signature of recurrence-associated endothelial cells predicts tumor progression and castration resistance in prostate cancer (2024 · British Journal of Cancer · 被引 4)
• Editorial Expression of Concern: Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7 (2023 · Molecular Cancer · 被引 3)
• Dynamic mixed-mode I/II fracture of sharp V-notched rocks: a combined MFFM and DIC study (2026 · Engineering Fracture Mechanics · 被引 2)